Kotak Healthcare Fund vs Nippon India Pharma Fund compare
Kotak Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹416 Cr | ₹8161 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 11 Dec 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.39 | 1.82 |
Manager | Abhishek Bisen | Sailesh Raj Bhan |
ISIN Code | INF174KA1PW4 | INF204K01968 |
Exits Load | Kotak Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -9.04% | -6% |
6 Month | -7.42% | -8.47% |
1 Year | 6.69% | 6.77% |
3 Year | - | 18.71% |
5 Year | - | 22.93% |
SIP Return Analysis
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | - | - |
1 Year | -3.27% | -2.3% |
3 Year | - | 21.23% |
5 Year | - | 19.2% |
Rolling Lumpsum Returns
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 31.01% | 18.19% |
3 Year | - | 20.5% |
5 Year | - | 20.36% |
Risk Management
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 15.185% |
Sharp | - | 0.81% |
Beta | - | 0.931% |
Alpha | - | -0.33% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Abhishek Bisen | Sailesh Raj Bhan |
Total AUM | ₹0 Cr | ₹96086 Cr |
Fund Manage | 33 | 5 |
Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.31 | 4.4 |
Small Cap | 24.27 | 22.52 |
Large Cap | 51.29 | 45.96 |
Mid Cap | 22.8 | 27.12 |
Sector Allocation
Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.31 | 4.4 |
Pharmaceuticals & Biotechnology | 79.49 | 75.86 |
Healthcare Services | 17.64 | 17.38 |
Insurance | 1.23 | - |
Retailing | - | 2.36 |
Top Comparisons
Canara Robeco Liquid Fund - Regular Plan - Growth Option
3Y Returns6.6%
Axis Liquid Fund - Regular Plan - Growth Option
3Y Returns6.61%
SBI Large & MIDCap Fund- Regular Plan -Growth
3Y Returns15.84%
DSP Equity Opportunities Fund-Regular Plan - Growth
3Y Returns17.62%
HDFC Gilt Fund - Growth Plan
3Y Returns6.04%
Nippon India Gilt Securities Fund -Growth Plan - Growth Option
3Y Returns6%
ICICI Prudential Smallcap Fund - Growth
3Y Returns16.33%
SBI Small Cap Fund - Regular Plan - Growth
3Y Returns14.97%